Icosavax, Inc.
ICVX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $582 | $7,802 | $1,616 | $0 |
| % Growth | -92.5% | 382.8% | – | – |
| Cost of Goods Sold | $1,843 | $82 | $17,667 | $4,157 |
| Gross Profit | -$1,261 | $7,720 | -$16,051 | -$4,157 |
| % Margin | -216.7% | 98.9% | -993.3% | – |
| R&D Expenses | $65,410 | $38,776 | $17,667 | $4,157 |
| G&A Expenses | $30,230 | $34,887 | $2,659 | $1,241 |
| SG&A Expenses | $30,230 | $34,887 | $2,659 | $1,241 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$582 | -$7,802 | -$1,616 | $0 |
| Operating Expenses | $95,058 | $65,861 | $18,710 | $5,398 |
| Operating Income | -$95,058 | -$65,861 | -$18,710 | -$5,398 |
| % Margin | -16,333% | -844.2% | -1,157.8% | – |
| Other Income/Exp. Net | $3,300 | -$1,110 | -$144 | $101 |
| Pre-Tax Income | -$91,758 | -$66,971 | -$18,854 | -$5,297 |
| Tax Expense | -$3,300 | $1,028 | $331 | -$101 |
| Net Income | -$88,458 | -$67,999 | -$19,185 | -$5,196 |
| % Margin | -15,199% | -871.6% | -1,187.2% | – |
| EPS | -2.23 | -3.78 | -6.67 | -0.51 |
| % Growth | 41% | 43.3% | -1,207.8% | – |
| EPS Diluted | -2.23 | -3.78 | -6.67 | -0.51 |
| Weighted Avg Shares Out | 39,725 | 17,966 | 2,878 | 10,241 |
| Weighted Avg Shares Out Dil | 39,725 | 17,966 | 2,878 | 10,241 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $151 | $331 | $101 |
| Interest Expense | $0 | $151 | $331 | $0 |
| Depreciation & Amortization | $860 | $959 | $1 | $172 |
| EBITDA | -$94,198 | -$64,902 | -$18,522 | -$5,398 |
| % Margin | -16,185.2% | -831.9% | -1,146.2% | – |